Home › Cardinal Health to manufacture Bayer cancer drug in new Indiana facility
 

Keywords :   


Cardinal Health to manufacture Bayer cancer drug in new Indiana facility

2014-12-23 08:47:36| Chemicals - Topix.net

Bayer HealthCare and Cardinal Health have signed a 15-year agreement for the contract manufacturing of the castration-resistant prostate cancer drug Xofigo . Under the agreement, Cardinal Health will build a state-of-the art, 64,000 square foot facility in Indianapolis, which will be dedicated exclusively to the manufacturing of Xofigo.

Tags: health drug cancer facility

Category:Chemicals

Latest from this category

All news
26.11ROSS VersaMix Multi Shaft Mixers are for Complex Formulations
26.11PPG Completes Sale of Silicas Products Business to QEMETICA
26.11¦nie¿ka Among Leaders of Sustainable Development in Poland
26.11Solvay Unveils Climate and Water Projects in Brazil with HRH Princess Astrid of Belgium
25.11PPG Recognized in Newsweeks Americas Greenest Companies List
25.11Axalta Wins Another Distinguished R&D 100 Award for Innovation
25.11Dunn-Edwards CEO Karl Altergott to Retire, COO Monte Lewis is Successor
25.11Global Market Insights: Auto Refinish Coating Market $17.79 Billion by 2032
Chemicals »
26.11JELEEBOX
26.11
26.11222CB
26.11BOSS ( ) BB-1X Bass Driver
26.1112010 re0827-141
26.11
26.11 2021 EDITION
26.11DVD
More »